In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Arava, Leflunomide Drug Master File in Korea (Arava, Leflunomide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Arava, Leflunomide. The MFDS reviews the Arava, Leflunomide KDMF as part of the drug registration process and uses the information provided in the Arava, Leflunomide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Arava, Leflunomide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Arava, Leflunomide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Arava, Leflunomide suppliers with KDMF on PharmaCompass.